BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1956550)

  • 1. Cyclophosphamide pulse therapy in Wegener's granulomatosis.
    Haubitz M; Frei U; Rother U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1991; 6(8):531-5. PubMed ID: 1956550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
    Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
    Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    Hoffman GS; Leavitt RY; Fleisher TA; Minor JR; Fauci AS
    Am J Med; 1990 Oct; 89(4):403-10. PubMed ID: 2220874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study.
    Drosos AA; Sakkas LI; Goussia A; Siamopoulos KC; Moutsopoulos HM
    J Intern Med; 1992 Sep; 232(3):279-82. PubMed ID: 1402626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of plasmapheresis with subsequent pulse cyclophosphamide as initial treatment of severe Wegener's granulomatosis.
    Heer A; Schroeder JO; Euler HH
    APMIS Suppl; 1990; 19():66. PubMed ID: 2285546
    [No Abstract]   [Full Text] [Related]  

  • 8. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.
    Reinhold-Keller E; Kekow J; Schnabel A; Schmitt WH; Heller M; Beigel A; Duncker G; Gross WL
    Arthritis Rheum; 1994 Jun; 37(6):919-24. PubMed ID: 8003065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Wegener's granulomatosis.
    Briedigkeit L; Ulmer M; Göbel U; Natusch R; Reinhold-Keller E; Gross WL
    Adv Exp Med Biol; 1993; 336():491-5. PubMed ID: 8296663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener's granulomatosis.
    Mitrovic D; Popovic M; Stefanovic D; Glisic B; Dimitrijevic M
    Transplant Proc; 2001 May; 33(3):2378-9. PubMed ID: 11377566
    [No Abstract]   [Full Text] [Related]  

  • 12. Wegener's granulomatosis.
    Sneller MC
    JAMA; 1995 Apr; 273(16):1288-91. PubMed ID: 7715042
    [No Abstract]   [Full Text] [Related]  

  • 13. Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.
    Steppat D; Gross WL
    Klin Wochenschr; 1989 Jul; 67(13):666-71. PubMed ID: 2787871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of bronchial stenosis in Wegener's granulomatosis. Dramatic response to intravenous cyclophosphamide and oral cotrimoxazole.
    Hirsch MM; Houssiau FA; Collard P; Devogelaer JP; Nagant de Deuxchaisnes C
    J Rheumatol; 1992 May; 19(5):821-4. PubMed ID: 1613718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
    Haubitz M; Koch KM; Brunkhorst R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Wegener's granulomatosis].
    Riccieri V; Valesini G
    Reumatismo; 2004; 56(2):69-76. PubMed ID: 15309213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis.
    Harrison HL; Linshaw MA; Lindsley CB; Cuppage FE
    JAMA; 1980 Oct; 244(14):1599-600. PubMed ID: 7420662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis].
    Kovacević Z; Mitrović D; Tomić I; Jovanović D; Skatarić V; Dimitrijević J; Rabrenović V; Trifunović G
    Vojnosanit Pregl; 1999; 56(1):31-7. PubMed ID: 10230331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.